NIH-funded research R03 grant

CNTNAP2: How a nerve protein may help ovarian cancer spread in the abdomen

Official title: An Autism-associated Protein CNTNAP2 Promotes Peritoneal Adhesion of Ovarian Cancer Cells

Funded at University of Illinois at Chicago · NIH-11437637 · Data updated 2026-11-12

A small NIH grant is studying whether a protein involved in nerves, CNTNAP2, helps ovarian cancer cells stick and spread in the abdomen.

More Ovarian Cancer research and trials

Quick facts

Grant typeR03 grant
Study typeNIH-funded research
Funding institutionUniversity of Illinois at Chicago
NIH-funded
Lab location1 site (Chicago, UNITED STATES)
Project startSeptember 15, 2026
Project endAugust 31, 2028
Funding year2026
Award (this year)$76,601
NIH project number1R03CA317617-01
Project IDNIH-11437637 on NIH RePORTER

Who could benefit from this research

Could help

Not applicable here; this grant is a basic science study using cell and tissue models.

Less likely to help

Direct patient benefit is not guaranteed; the study is preclinical.

What this research studies

This project looks at how cancer cells that have moved from the ovary interact with nerve fibers in the peritoneal cavity and how that contact might promote new tumor sites. The researchers will examine molecular signals that enable cancer cells to adhere to nerves and other lining cells, aiming to uncover targets to prevent spread. The work uses laboratory experiments to understand the biology behind peritoneal adhesion and metastatic seeding. If successful, the findings could point to new ways to limit metastasis and improve outcomes for people with advanced ovarian cancer.

Why it matters

Potential benefit: Understanding this adhesion mechanism could lead to new approaches to prevent or slow metastatic spread in ovarian cancer.

How similar studies have gone: Other studies have shown nerve-tumor interactions can influence metastasis, but the CNTNAP2 nerve-adhesion link in ovarian cancer is exploratory.

Where this research is happening

  • University of Illinois at Chicago
    Chicago, United States
    Active

Researchers

  • Principal investigator: Barbolina, Maria V. — University of Illinois at Chicago
  • Study coordinator: Barbolina, Maria V.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.